Entera Bio ENTX
NASDAQ ENTX
$3.24 +0.02 (+0.62%)
As of: Aug 21, 2026 · 3:59 PM EDT

Entera Bio (ENTX) Operating Margin (QoQ) (2021 - 2025)

Entera Bio (ENTX) Operating Margin (QoQ) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Entera Bio 161.44 Mn 150.13 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 -325,238.00
Dec 31, 2024 434,286.00
Sep 30, 2024 -333,321.00
Dec 31, 2022 1.39 Mn
Sep 30, 2022 -2.84 Mn
Jun 30, 2022 -174,439.00
Mar 31, 2022 -316,213.00
Dec 31, 2021 -17,758.00
Sep 30, 2021 5,780.00
Jun 30, 2021 -86,799.00